trial · primary record
Pembrolizumab
Head and Neck Cancer
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 6 |
| Primary completion | 2028-03 |
| Primary endpoint | Number of Participants who complete all planned treatment cycles |
| Registry ID | NCT07501650 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:38:59.405Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07501650
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- PEMBROLIZUMAB · approval
- Pembrolizumab · compound